<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Super Antioxidant</title>
	<atom:link href="http://www.super-antioxidant.org/feed" rel="self" type="application/rss+xml" />
	<link>http://www.super-antioxidant.org</link>
	<description>Glutathione - the master antioxidant</description>
	<lastBuildDate>Tue, 09 Feb 2010 07:33:00 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>The many faces of scleroderma sine scleroderma: a literature review focusing on cardiopulmonary complications</title>
		<link>http://www.super-antioxidant.org/the-many-faces-of-scleroderma-sine-scleroderma-a-literature-review-focusing-on-cardiopulmonary-complications</link>
		<comments>http://www.super-antioxidant.org/the-many-faces-of-scleroderma-sine-scleroderma-a-literature-review-focusing-on-cardiopulmonary-complications#comments</comments>
		<pubDate>Tue, 09 Feb 2010 07:33:00 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Object]]></category>
		<category><![CDATA[108-published]]></category>
		<category><![CDATA[absence]]></category>
		<category><![CDATA[all-patients]]></category>
		<category><![CDATA[collected-all]]></category>
		<category><![CDATA[internal-organs]]></category>
		<category><![CDATA[often-lethal]]></category>
		<category><![CDATA[published-cases]]></category>
		<category><![CDATA[such-as-the]]></category>
		<category><![CDATA[systemic]]></category>
		<category><![CDATA[the-clinical]]></category>
		<category><![CDATA[the-diagnosis]]></category>
		<category><![CDATA[treat-the-often]]></category>
		<category><![CDATA[vascular-system]]></category>
		<category><![CDATA[were-present]]></category>

		<guid isPermaLink="false">http://www.super-antioxidant.org/the-many-faces-of-scleroderma-sine-scleroderma-a-literature-review-focusing-on-cardiopulmonary-complications</guid>
		<description><![CDATA[Scleroderma sine scleroderma (ssSSc) is an occult form of systemic sclerosis that may cause diagnostic difficulties due to the absence of skin involvement. Delays in the diagnosis of ssSSc means lost opportunites to address and treat the often lethal involvement of internal organs such as the lungs and heart. ]]></description>
			<content:encoded><![CDATA[<p>See the original post:</p>
<p>http://antioxidant-scleroderma.blogspot.com/2010/02/many-faces-of-scleroderma-sine.html</p>
<blockquote><p>
Scleroderma sine scleroderma (ssSSc) is an occult form of systemic sclerosis that may cause diagnostic difficulties due to the absence of skin involvement. Delays in the diagnosis of ssSSc means lost opportunites to address and treat the often lethal involvement of internal organs such as the lungs and heart.
</p></blockquote>
]]></content:encoded>
			<wfw:commentRss>http://www.super-antioxidant.org/the-many-faces-of-scleroderma-sine-scleroderma-a-literature-review-focusing-on-cardiopulmonary-complications/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Non-Hodgkin&#8217;s lymphoma in systemic sclerosis: case and literature review.</title>
		<link>http://www.super-antioxidant.org/non-hodgkins-lymphoma-in-systemic-sclerosis-case-and-literature-review</link>
		<comments>http://www.super-antioxidant.org/non-hodgkins-lymphoma-in-systemic-sclerosis-case-and-literature-review#comments</comments>
		<pubDate>Tue, 09 Feb 2010 07:31:00 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Object]]></category>
		<category><![CDATA[108-published]]></category>
		<category><![CDATA[absence]]></category>
		<category><![CDATA[all-patients]]></category>
		<category><![CDATA[english]]></category>
		<category><![CDATA[lymphoma-onset]]></category>
		<category><![CDATA[our-scleroderma]]></category>
		<category><![CDATA[primary-gastric]]></category>
		<category><![CDATA[published-cases]]></category>
		<category><![CDATA[ssc and gi tract]]></category>
		<category><![CDATA[such-as-the]]></category>
		<category><![CDATA[systemic]]></category>
		<category><![CDATA[the-clinical]]></category>

		<guid isPermaLink="false">http://www.super-antioxidant.org/non-hodgkins-lymphoma-in-systemic-sclerosis-case-and-literature-review</guid>
		<description><![CDATA[ Clin Rheumatol. 2010 Jan;29(1):1-6. Epub 2009 Oct 7. ]]></description>
			<content:encoded><![CDATA[<p>Continued here:</p>
<p>http://antioxidant-scleroderma.blogspot.com/2010/02/non-hodgkins-lymphoma-in-systemic.html</p>
<blockquote><p>
 Clin Rheumatol. 2010 Jan;29(1):1-6. Epub 2009 Oct 7.
</p></blockquote>
]]></content:encoded>
			<wfw:commentRss>http://www.super-antioxidant.org/non-hodgkins-lymphoma-in-systemic-sclerosis-case-and-literature-review/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Why the Conventional Treatment of Scleroderma is Flawed</title>
		<link>http://www.super-antioxidant.org/why-the-conventional-treatment-of-scleroderma-is-flawed</link>
		<comments>http://www.super-antioxidant.org/why-the-conventional-treatment-of-scleroderma-is-flawed#comments</comments>
		<pubDate>Tue, 09 Feb 2010 02:11:00 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Object]]></category>
		<category><![CDATA[a-hardens-and]]></category>
		<category><![CDATA[a-major-factor]]></category>
		<category><![CDATA[accumulation]]></category>
		<category><![CDATA[body]]></category>
		<category><![CDATA[condition]]></category>
		<category><![CDATA[development]]></category>
		<category><![CDATA[disorder]]></category>
		<category><![CDATA[pathogenic-nano]]></category>
		<category><![CDATA[school]]></category>
		<category><![CDATA[scleroderma]]></category>
		<category><![CDATA[source]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.super-antioxidant.org/why-the-conventional-treatment-of-scleroderma-is-flawed</guid>
		<description><![CDATA[Scleroderma is a relatively common and often debilitating condition. In light of that, one might reasonably assume that scientists and medical professionals would be able to devise a successful method for the treatment of the disorder. ]]></description>
			<content:encoded><![CDATA[<p>See the original post: </p>
<p>http://antioxidant-scleroderma.blogspot.com/2010/02/why-conventional-treatment-of.html</p>
<blockquote><p>
Scleroderma is a relatively common and often debilitating condition. In light of that, one might reasonably assume that scientists and medical professionals would be able to devise a successful method for the treatment of the disorder.
</p></blockquote>
]]></content:encoded>
			<wfw:commentRss>http://www.super-antioxidant.org/why-the-conventional-treatment-of-scleroderma-is-flawed/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The 2 Types of Scleroderma</title>
		<link>http://www.super-antioxidant.org/the-2-types-of-scleroderma</link>
		<comments>http://www.super-antioxidant.org/the-2-types-of-scleroderma#comments</comments>
		<pubDate>Tue, 09 Feb 2010 02:08:00 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Object]]></category>
		<category><![CDATA[a-takes-two]]></category>
		<category><![CDATA[condition]]></category>
		<category><![CDATA[disorder]]></category>
		<category><![CDATA[management]]></category>
		<category><![CDATA[method-relieves]]></category>
		<category><![CDATA[opens-the-door]]></category>
		<category><![CDATA[same]]></category>
		<category><![CDATA[skin]]></category>
		<category><![CDATA[source]]></category>

		<guid isPermaLink="false">http://www.super-antioxidant.org/the-2-types-of-scleroderma</guid>
		<description><![CDATA[ What is Scleroderma? Scleroderma refers to a widespread disease afflicting connective tissues. It can produce deleterious changes in internal organs, muscles, blood vessels and the skin]]></description>
			<content:encoded><![CDATA[<p>Original post:</p>
<p>http://antioxidant-scleroderma.blogspot.com/2010/02/2-types-of-scleroderma.html</p>
<blockquote><p>
 What is Scleroderma? Scleroderma refers to a widespread disease afflicting connective tissues. It can produce deleterious changes in internal organs, muscles, blood vessels and the skin
</p></blockquote>
]]></content:encoded>
			<wfw:commentRss>http://www.super-antioxidant.org/the-2-types-of-scleroderma/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Does Cherry Juice Really Help Gout and Arthritis Pain?</title>
		<link>http://www.super-antioxidant.org/does-cherry-juice-really-help-gout-and-arthritis-pain</link>
		<comments>http://www.super-antioxidant.org/does-cherry-juice-really-help-gout-and-arthritis-pain#comments</comments>
		<pubDate>Mon, 08 Feb 2010 10:29:00 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Object]]></category>
		<category><![CDATA[a-local-health]]></category>
		<category><![CDATA[a-natural-way]]></category>
		<category><![CDATA[article]]></category>
		<category><![CDATA[cherry]]></category>
		<category><![CDATA[published]]></category>
		<category><![CDATA[skin]]></category>
		<category><![CDATA[source]]></category>
		<category><![CDATA[stomach]]></category>
		<category><![CDATA[wheelchair]]></category>

		<guid isPermaLink="false">http://www.super-antioxidant.org/does-cherry-juice-really-help-gout-and-arthritis-pain</guid>
		<description><![CDATA[ I Keep On Baking Because I Think It'll make You Love Me by littlebluepenguin featuring Alexander McQueen tops The question many joint pain suffers are asking is does tart cherry juice reduces joint pain caused by gout and arthritis? Will this natural product help to reduce pain with less side effects than prescription drugs. Let's look at the published research dating back to the 1950's to begin our examination of the tart cherry. ]]></description>
			<content:encoded><![CDATA[<p>The rest is here: </p>
<p>http://antioxidant-scleroderma.blogspot.com/2010/02/does-cherry-juice-really-help-gout-and.html</p>
<blockquote><p>
 I Keep On Baking Because I Think It&#8217;ll make You Love Me by littlebluepenguin featuring Alexander McQueen tops The question many joint pain suffers are asking is does tart cherry juice reduces joint pain caused by gout and arthritis? Will this natural product help to reduce pain with less side effects than prescription drugs. Let&#8217;s look at the published research dating back to the 1950&#8217;s to begin our examination of the tart cherry.
</p></blockquote>
]]></content:encoded>
			<wfw:commentRss>http://www.super-antioxidant.org/does-cherry-juice-really-help-gout-and-arthritis-pain/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Health Benefits of Zinc</title>
		<link>http://www.super-antioxidant.org/the-health-benefits-of-zinc</link>
		<comments>http://www.super-antioxidant.org/the-health-benefits-of-zinc#comments</comments>
		<pubDate>Mon, 08 Feb 2010 07:27:00 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Object]]></category>
		<category><![CDATA[a-lesser-degree]]></category>
		<category><![CDATA[cherry]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[health-websites]]></category>
		<category><![CDATA[nutrition]]></category>
		<category><![CDATA[published]]></category>
		<category><![CDATA[recommended]]></category>
		<category><![CDATA[supports-normal]]></category>

		<guid isPermaLink="false">http://www.super-antioxidant.org/the-health-benefits-of-zinc</guid>
		<description><![CDATA[Zinc is a mineral found in almost every cell and is an essential nutrient for the body. Zinc is available in various food sources and is also made available as supplements (as single-ingredient or multi-vitamins)]]></description>
			<content:encoded><![CDATA[<p>See the rest here:</p>
<p>http://antioxidant-scleroderma.blogspot.com/2010/02/health-benefits-of-zinc.html</p>
<blockquote><p>
Zinc is a mineral found in almost every cell and is an essential nutrient for the body. Zinc is available in various food sources and is also made available as supplements (as single-ingredient or multi-vitamins)
</p></blockquote>
]]></content:encoded>
			<wfw:commentRss>http://www.super-antioxidant.org/the-health-benefits-of-zinc/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Localized scleroderma and zinc: a pilot study.</title>
		<link>http://www.super-antioxidant.org/localized-scleroderma-and-zinc-a-pilot-study</link>
		<comments>http://www.super-antioxidant.org/localized-scleroderma-and-zinc-a-pilot-study#comments</comments>
		<pubDate>Mon, 08 Feb 2010 07:06:00 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Object]]></category>
		<category><![CDATA[a-active-for]]></category>
		<category><![CDATA[a-mean-dose]]></category>
		<category><![CDATA[been-proposed]]></category>
		<category><![CDATA[efficacy]]></category>
		<category><![CDATA[patient]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[the-physician]]></category>
		<category><![CDATA[the-treatment]]></category>
		<category><![CDATA[treatments-have]]></category>

		<guid isPermaLink="false">http://www.super-antioxidant.org/localized-scleroderma-and-zinc-a-pilot-study</guid>
		<description><![CDATA[ Eur J Dermatol. 2010 Feb 2 Esthetic or functional repercussions in localized scleroderma may be considerable. Numerous treatments have been proposed with limited effectiveness. ]]></description>
			<content:encoded><![CDATA[<p>An interesting post from:</p>
<p>http://antioxidant-scleroderma.blogspot.com/2010/02/localized-scleroderma-and-zinc-pilot.html</p>
<blockquote><p>
 Eur J Dermatol. 2010 Feb 2 Esthetic or functional repercussions in localized scleroderma may be considerable. Numerous treatments have been proposed with limited effectiveness.
</p></blockquote>
]]></content:encoded>
			<wfw:commentRss>http://www.super-antioxidant.org/localized-scleroderma-and-zinc-a-pilot-study/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Autoantibodies as predictive tools in systemic sclerosis.</title>
		<link>http://www.super-antioxidant.org/autoantibodies-as-predictive-tools-in-systemic-sclerosis</link>
		<comments>http://www.super-antioxidant.org/autoantibodies-as-predictive-tools-in-systemic-sclerosis#comments</comments>
		<pubDate>Mon, 08 Feb 2010 07:04:00 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Object]]></category>
		<category><![CDATA[a-mean-dose]]></category>
		<category><![CDATA[and-disease]]></category>
		<category><![CDATA[been-proposed]]></category>
		<category><![CDATA[efficacy]]></category>
		<category><![CDATA[patients-with]]></category>
		<category><![CDATA[presence]]></category>
		<category><![CDATA[the-others-]]></category>
		<category><![CDATA[the-physician]]></category>
		<category><![CDATA[treatments-have]]></category>

		<guid isPermaLink="false">http://www.super-antioxidant.org/autoantibodies-as-predictive-tools-in-systemic-sclerosis</guid>
		<description><![CDATA[ Nat Rev Rheumatol. 2010 Feb;6(2):112-6. ]]></description>
			<content:encoded><![CDATA[<p>More here:</p>
<p>http://antioxidant-scleroderma.blogspot.com/2010/02/autoantibodies-as-predictive-tools-in.html</p>
<blockquote><p>
 Nat Rev Rheumatol. 2010 Feb;6(2):112-6.
</p></blockquote>
]]></content:encoded>
			<wfw:commentRss>http://www.super-antioxidant.org/autoantibodies-as-predictive-tools-in-systemic-sclerosis/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis.</title>
		<link>http://www.super-antioxidant.org/mechanisms-in-the-loss-of-capillaries-in-systemic-sclerosis-angiogenesis-versus-vasculogenesis</link>
		<comments>http://www.super-antioxidant.org/mechanisms-in-the-loss-of-capillaries-in-systemic-sclerosis-angiogenesis-versus-vasculogenesis#comments</comments>
		<pubDate>Mon, 08 Feb 2010 07:02:00 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Object]]></category>
		<category><![CDATA[a-and-severe]]></category>
		<category><![CDATA[and-disease]]></category>
		<category><![CDATA[efficacy]]></category>
		<category><![CDATA[hypoxia-induces]]></category>
		<category><![CDATA[response-during]]></category>
		<category><![CDATA[skin]]></category>
		<category><![CDATA[such-as-digital]]></category>
		<category><![CDATA[the-physician]]></category>
		<category><![CDATA[tissue-ischemia]]></category>
		<category><![CDATA[towards-chronic]]></category>
		<category><![CDATA[understanding]]></category>
		<category><![CDATA[vascular-injury]]></category>
		<category><![CDATA[with-consequent]]></category>

		<guid isPermaLink="false">http://www.super-antioxidant.org/mechanisms-in-the-loss-of-capillaries-in-systemic-sclerosis-angiogenesis-versus-vasculogenesis</guid>
		<description><![CDATA[ J Cell Mol Med. 2010 Jan 30 Abstract Systemic sclerosis (SSc, scleroderma) is a chronic, multisystem connective tissue disorder affecting the skin and various internal organs. ]]></description>
			<content:encoded><![CDATA[<p>Read the original:</p>
<p>http://antioxidant-scleroderma.blogspot.com/2010/02/mechanisms-in-loss-of-capillaries-in.html</p>
<blockquote><p>
 J Cell Mol Med. 2010 Jan 30 Abstract Systemic sclerosis (SSc, scleroderma) is a chronic, multisystem connective tissue disorder affecting the skin and various internal organs.
</p></blockquote>
]]></content:encoded>
			<wfw:commentRss>http://www.super-antioxidant.org/mechanisms-in-the-loss-of-capillaries-in-systemic-sclerosis-angiogenesis-versus-vasculogenesis/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Musculoskeletal rehabilitation in the person with scleroderma</title>
		<link>http://www.super-antioxidant.org/musculoskeletal-rehabilitation-in-the-person-with-scleroderma</link>
		<comments>http://www.super-antioxidant.org/musculoskeletal-rehabilitation-in-the-person-with-scleroderma#comments</comments>
		<pubDate>Mon, 08 Feb 2010 03:06:00 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Object]]></category>
		<category><![CDATA[are-promising]]></category>
		<category><![CDATA[examine-current]]></category>
		<category><![CDATA[face-stretching]]></category>
		<category><![CDATA[four-randomized]]></category>
		<category><![CDATA[hand-function]]></category>
		<category><![CDATA[results]]></category>
		<category><![CDATA[review]]></category>
		<category><![CDATA[small-studies]]></category>
		<category><![CDATA[the-majority]]></category>

		<guid isPermaLink="false">http://www.super-antioxidant.org/musculoskeletal-rehabilitation-in-the-person-with-scleroderma</guid>
		<description><![CDATA[ By Poole JL. PURPOSE OF REVIEW: The purpose of this review is to examine current evidence for the efficacy of rehabilitation techniques for musculoskeletal impairments in persons with scleroderma. RECENT FINDINGS: The current literature on rehabilitation techniques consists of studies evaluating the effectiveness of paraffin wax treatment, hand and face stretching exercises, connective tissue massage and joint manipulation, splints, and aerobic exercise and resistance training]]></description>
			<content:encoded><![CDATA[<p>Original post: </p>
<p>http://antioxidant-scleroderma.blogspot.com/2010/02/musculoskeletal-rehabilitation-in.html</p>
<blockquote><p>
 By Poole JL. PURPOSE OF REVIEW: The purpose of this review is to examine current evidence for the efficacy of rehabilitation techniques for musculoskeletal impairments in persons with scleroderma. RECENT FINDINGS: The current literature on rehabilitation techniques consists of studies evaluating the effectiveness of paraffin wax treatment, hand and face stretching exercises, connective tissue massage and joint manipulation, splints, and aerobic exercise and resistance training
</p></blockquote>
]]></content:encoded>
			<wfw:commentRss>http://www.super-antioxidant.org/musculoskeletal-rehabilitation-in-the-person-with-scleroderma/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
